Related Experiment Video
Updated: Jun 8, 2025

Evaluating the Differentiation Capacity of Mouse Prostate Epithelial Cells Using Organoid Culture
Published on: November 22, 2019
KIF1A promotes neuroendocrine differentiation in prostate cancer by regulating the OGT-mediated O-GlcNAcylation
Qianqian Zhou1, Muyi Yang2, Jiawei Fu1
1The Key Laboratory of Experimental Teratology, Ministry of Education and Department of Pathology, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250000, P R China.
Abstract:
Neuroendocrine prostate cancer (NEPC) arises from prostate adenocarcinoma after endocrine treatment failure and implies lethality and limited therapeutic options. Deciphering the molecular mechanisms underlying transdifferentiation from adenocarcinoma to NEPC may provide valuable therapeutic strategies. We performed a pan-cancer differential mRNA abundance analysis and identified that Kinesin-like protein (KIF1A) was highly expressed in NEPC. KIF1A knockdown impaired neuroendocrine(NE) features, including NE marker gene expression, stemness, and epithelial-mesenchymal transition (EMT), whereas KIF1A overexpression promoted these processes. Targeting KIF1A inhibited the growth of NE differentiated prostate cancer (PCa) cells in vitro and in vivo. Mechanistically, KIF1A bound with O-linked N-acetylglucosamine transferase (OGT) and regulated its protein expression and activity. Nuclear accumulation of OGT induced by KIF1A overexpression promoted intranuclear O-GlcNAcylation of β-catenin and OCT4 in nucleus. More importantly, our data revealed that OGT was critical for KIF1A induced NE differentiation and aggressive tumor growth. An OGT inhibitor, OSMI-1, can significantly inhibited NE differentiated PCa cell proliferation in vitro and tumor growth in vivo. Our findings showed that KIF1A promotes NE differentiation to NEPC by regulating the OGT-mediated O-GlcNAcylation. Targeting O-GlcNAcylation may impede the development of NEPC for a group of PCa patients with elevated KIF1A expression.
Insights
Kinesin-like protein 1A (KIF1A) drives neuroendocrine prostate cancer (NEPC) progression by enhancing O-linked N-acetylglucosamine transferase (OGT) activity. Targeting KIF1A or O-GlcNAcylation may offer new therapeutic strategies for NEPC.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Neuroendocrine prostate cancer (NEPC) is an aggressive subtype of prostate cancer with poor prognosis.
- Understanding the molecular mechanisms of NEPC development is crucial for identifying new therapeutic targets.
Purpose of the Study:
- To investigate the role of Kinesin-like protein 1A (KIF1A) in NEPC development and identify its downstream molecular targets.
- To explore the therapeutic potential of targeting KIF1A and O-linked N-acetylglucosamine transferase (OGT) in NEPC.
Main Methods:
- Pan-cancer differential mRNA abundance analysis to identify key genes.
- KIF1A knockdown and overexpression experiments in prostate cancer cell lines.
- In vitro and in vivo assays to assess tumor growth and NE differentiation.
- Co-immunoprecipitation and Western blot analyses to investigate protein interactions and modifications.
Main Results:
- KIF1A was highly expressed in NEPC and promoted neuroendocrine differentiation, stemness, and epithelial-mesenchymal transition (EMT).
- KIF1A directly interacted with OGT, enhancing its activity and promoting intranuclear O-GlcNAcylation of key transcription factors.
- Targeting KIF1A or OGT with inhibitors significantly suppressed NEPC cell proliferation and tumor growth in vitro and in vivo.
Conclusions:
- KIF1A promotes NEPC development by regulating OGT-mediated O-GlcNAcylation, representing a potential therapeutic vulnerability.
- Targeting KIF1A or O-GlcNAcylation pathways may offer novel treatment strategies for patients with advanced prostate cancer and NEPC phenotype.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
PI3K/mTOR/AKT Signaling Pathway
Mitogens and the Cell Cycle
Proteoglycans

